450 related articles for article (PubMed ID: 20971955)
1. Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.
Hinrichs CS; Borman ZA; Gattinoni L; Yu Z; Burns WR; Huang J; Klebanoff CA; Johnson LA; Kerkar SP; Yang S; Muranski P; Palmer DC; Scott CD; Morgan RA; Robbins PF; Rosenberg SA; Restifo NP
Blood; 2011 Jan; 117(3):808-14. PubMed ID: 20971955
[TBL] [Abstract][Full Text] [Related]
2. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
3. Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity.
Hinrichs CS; Borman ZA; Cassard L; Gattinoni L; Spolski R; Yu Z; Sanchez-Perez L; Muranski P; Kern SJ; Logun C; Palmer DC; Ji Y; Reger RN; Leonard WJ; Danner RL; Rosenberg SA; Restifo NP
Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17469-74. PubMed ID: 19805141
[TBL] [Abstract][Full Text] [Related]
4. Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.
Crompton JG; Sukumar M; Restifo NP
Immunol Rev; 2014 Jan; 257(1):264-276. PubMed ID: 24329803
[TBL] [Abstract][Full Text] [Related]
5. Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients.
Casati A; Varghaei-Nahvi A; Feldman SA; Assenmacher M; Rosenberg SA; Dudley ME; Scheffold A
Cancer Immunol Immunother; 2013 Oct; 62(10):1563-73. PubMed ID: 23903715
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-like plasticity of naïve and distinct memory CD8+ T cell subsets.
Stemberger C; Neuenhahn M; Gebhardt FE; Schiemann M; Buchholz VR; Busch DH
Semin Immunol; 2009 Apr; 21(2):62-8. PubMed ID: 19269852
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.
Wu RC; Liu S; Chacon JA; Wu S; Li Y; Sukhumalchandra P; Murray JL; Molldrem JJ; Hwu P; Pircher H; Lizée G; Radvanyi LG
Clin Cancer Res; 2012 May; 18(9):2465-77. PubMed ID: 22307139
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of Diverse Progenies of Memory T Cells from Naïve CD8
Zanon V; Lugli E
Methods Mol Biol; 2017; 1514():103-110. PubMed ID: 27787795
[TBL] [Abstract][Full Text] [Related]
9. Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity.
Boudousquié C; Danilo M; Pousse L; Jeevan-Raj B; Angelov GS; Chennupati V; Zehn D; Held W
J Immunol; 2014 Sep; 193(6):2784-91. PubMed ID: 25127860
[TBL] [Abstract][Full Text] [Related]
10. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
[TBL] [Abstract][Full Text] [Related]
11. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.
Romero P; Zippelius A; Kurth I; Pittet MJ; Touvrey C; Iancu EM; Corthesy P; Devevre E; Speiser DE; Rufer N
J Immunol; 2007 Apr; 178(7):4112-9. PubMed ID: 17371966
[TBL] [Abstract][Full Text] [Related]
12. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
13. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.
Kalyanasundaram Bhanumathy K; Zhang B; Xie Y; Xu A; Tan X; Xiang J
J Gene Med; 2015; 17(8-9):153-60. PubMed ID: 26212685
[TBL] [Abstract][Full Text] [Related]
14. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.
Hendriks J; Xiao Y; Rossen JW; van der Sluijs KF; Sugamura K; Ishii N; Borst J
J Immunol; 2005 Aug; 175(3):1665-76. PubMed ID: 16034107
[TBL] [Abstract][Full Text] [Related]
15. Induction of a VLA-2 (CD49b)-expressing effector T cell population by a cell-based neuroblastoma vaccine expressing CD137L.
Yan X; Johnson BD; Orentas RJ
J Immunol; 2008 Oct; 181(7):4621-31. PubMed ID: 18802064
[TBL] [Abstract][Full Text] [Related]
16. Adoptive immunotherapy of advanced tumors with CD62 L-selectin(low) tumor-sensitized T lymphocytes following ex vivo hyperexpansion.
Wang LX; Chen BG; Plautz GE
J Immunol; 2002 Sep; 169(6):3314-20. PubMed ID: 12218152
[TBL] [Abstract][Full Text] [Related]
17. CD7 is a differentiation marker that identifies multiple CD8 T cell effector subsets.
Aandahl EM; Sandberg JK; Beckerman KP; Taskén K; Moretto WJ; Nixon DF
J Immunol; 2003 Mar; 170(5):2349-55. PubMed ID: 12594257
[TBL] [Abstract][Full Text] [Related]
18. HLA-peptide multimer selection of adenovirus-specific T cells for adoptive T-cell therapy.
Chakupurakal G; Onion D; Bonney S; Cobbold M; Mautner V; Moss P
J Immunother; 2013 Oct; 36(8):423-31. PubMed ID: 23994889
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype.
Tomiyama H; Matsuda T; Takiguchi M
J Immunol; 2002 Jun; 168(11):5538-50. PubMed ID: 12023349
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]